Form 4: Sabra Health Care REIT Executive VP, CFO & Secretary Michael Lourenco Costa Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reports acquisition of 3,858 shares of common stock due to dividend equivalent payments and adjustments to holdings in IRA accounts.

Summary

  • On February 28, 2025, Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reported changes in beneficial ownership.
  • Costa acquired 3,858 shares of common stock due to dividend equivalent payments on previously granted stock units.
  • These stock units were credited under the Issuer's 2009 Performance Incentive Plan and will vest and become payable on the same terms as the original stock units.
  • The reporting person's direct holdings of common stock increased to 344,613 shares.
  • Costa also reported indirect ownership of 784 shares through his IRA and 207 shares through his spouse's IRA.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a routine disclosure of stock ownership changes. The acquisition of shares through dividend equivalents is a slightly positive sign, but not significantly impactful.

Positives

  • The acquisition of shares through dividend equivalent payments indicates a continued investment in the company by the executive.
  • The increase in direct ownership suggests confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the reporting of stock unit acquisitions suggests continued participation in the company's incentive plans.

Industry Context

This filing is a routine disclosure related to changes in beneficial ownership by a company executive, which is common in publicly traded companies. It provides transparency into the holdings and transactions of key personnel.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding the stock ownership of a key executive.
  • It assures stakeholders that executives are aligned with the company's performance through stock-based compensation.

Key Dates

DateDescription
02/28/2025Date of transaction (acquisition of shares)
03/04/2025Date of signature on the Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.